Predicting Survival in Patients with Neuroendocrine Prostate Cancer: A SEER-Based Comprehensive Study-Reference-Cited by-同舟云学术

Predicting Survival in Patients with Neuroendocrine Prostate Cancer: A SEER-Based Comprehensive Study

Published:2024 Issue: Volume:42 Page:
ISSN:2287-4208
Container-title:The World Journal of Men's Health
language:en
Short-container-title:World J Mens Health

Author:

Luo Tianlong¹^ORCID,Hu Jintao¹^ORCID,Cheng Bisheng¹^ORCID,Chen Peixian¹^ORCID,Fu Jianhan¹^ORCID,Zhong Haitao¹^ORCID,Han Jinli¹^ORCID,Huang Hai¹²³⁴^ORCID

Affiliation:

1. Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-Sen University, Guangzhou, China.

3. Guangdong Provincial Clinical Research Center for Urological Diseases, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

4. Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Guangdong, China.

Funder

National key R&D plan of China

National Natural Science Foundation of China

Key R&D Plan of Guangdong Province

International Science and technology cooperation project plan of Guangdong Province

Sun Yat-Sen University Clinical Research 5010 Program

Beijing Bethune Charitable Foundation

Guangzhou Science and Technology Key R&D Project

Beijing Xisike Clinical Oncology Research Foundation

Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital to Hai Huang

The Science and Technology Planning Project of Guangdong Province

Guangdong Provincial Clinical Research Center for Urological Diseases

Publisher

XMLink

Link

https://wjmh.org/pdf/10.5534/wjmh.240061

Reference29 articles.

1. Cancer statistics, 2023

2. MT1G, an emerging ferroptosis‐related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer

3. A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3

4. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer